Introduction
The pyrazole ring is found in numerous pharmaceutically active compounds. This is mainly due to the ease of preparation and the important biological activity. Many pyrazole derivatives have been reported to possess diverse pharmacological activities such as antimicrobial [1] [2] [3] [4] [5] [6] , anti-inflammatory [7] [8] [9] [10] , anti-viral [11, 12] , antidiabetic [13] , analgesic [14] and antiparasitic properties [15] .
Pyrazole showed promising anticancer effects [16] [17] [18] [19] [20] [21] [22] . In search for better antitumor treatment, a large number of pyrazole derivatives were synthesized and tested over the years, the use of this powerful pharmacophore is very popular and modern [23] [24] [25] . On the other hand, pyridine derivatives have occupied a unique position in medicinal chemistry, besides many naturally occurring pyridines. Several synthetic derivatives show interesting biological activities for example, 2-amino-3-cyanopyridines have antibacterial, antimicrobial, antifungal and cardiotonic activities [26, 27] . In connection with these findings and our interest in the synthesis of fused nitrogen heterocyclic compounds with 1 H NMR spectra were recorded on Bruker AC 200F 300 MHz spectrometer using TMS as an internal reference. 13 C NMR spectra were measured on a Varian spectrophotometer at 300 MHz, using DMSO-d 6 or CDCl 3 as solvent. The Electron Impact mass spectra were obtained at 70 eV using Shimadzu QP-2010 Plus mass spectrometer. The reactions were monitored by thin-layer chromatography (TLC) on silica gel F254 aluminum sheets (Merck), and spots were visualized by UV lamp at 254-365 nm. All cell culture material was obtained from Cambrex Bio Science (Copenhagen, Denmark). All chemicals were from Sigma/ Aldrich, USA, except mentioned. Human breast adenocarcinoma cell line (MCF-7) and human hepatocarcinoma cell line (Hep-G2), were purchased from ATCC, USA 
Chemistry
Synthesis of 1,3-diphenylpyrazole-4-carboxaldehyde 4 [28] To (0.01 mole) of acetophenonephenyl hydrazine, (0.01 mole) of Vilsmerier reagent (14.6 mL DMF and 19.10 mL POCl 3 ) was added dropwise with stirring for one hour. The reaction mixture was refluxed for six hours at 70-80°C, then hydrolyzed on ice/water mixture, and neutralized by 5% NaOH solution till pH 4, the solid formed was filtered, washed with water, dried and crystalized from isopropanol to give compound 4 as yellow white powder in (80%) yield, m.p. = 142-143°C, IR (KBr, cm [28, 29] To a solution of 1,3-diphenyl-1H-pyrazol-4-carboxaldehyde 4 (2.48 g, 0.01 mole), aryl methyl ketone 1a-d (0.01 mole) in ethanol (30 mL), a pellet of KOH was added. The reaction mixture was stirred at room temperature for overnight. The yellow solid precipitated was separated by filtration and recrystallized from (1 : 1) EtOH/ DMF mixture to give α-β-unsaturated compounds 5a-d. A solution of 1,3-diphenylpyrazole-4-carboxaldehyde 4 (2.48 g, 0.01 mole), aniline derivatives (0.01 mole), acetic acid (1 mL) and methanol (30mL) was refluxed for one hour (some yellow crystals formed under reflux condition). After cooling the reaction mixture was poured into crushed ice, the yellow product was filtered and recrystallized from ethyl acetate to give derivatives 11a-f.
General procedure for synthesis of 1-aryl-3-(1,3-diphenyl-1H-pyrazol-4-yl)prop-2-en-1-one 5a-d
(E)-3-(1,3-Diphenyl-1H-pyrazol-4-yl)-1- phenylprop-2-en-1-
1-(1,3-Diphenyl-1H-pyrazol-4-yl)-Nphenylmethanimine 11a
Yield 65%, m.p. 150-152°C.Anal. Calcd for 
1-(1,3-Diphenyl-1H-pyrazol-4-yl)-N-(p-tolyl) methanimine 11b
Yield 82%, m.p. 150-152°C. IR (KBr, cm 
1-(1,3-Diphenyl-1H-pyrazol-4-yl)-N-(4-nitrophenyl)methanimine 11c
Yield 60%, m.p. 142-144°C. Anal. Calcd for 
N-(4-Bromophenyl)-1-(1,3-diphenyl-1H-pyrazol-4-yl)methanimine 11d
Yield 58%, m.p. 168-170°C. Anal. Calcd for 
1-(1,3-Diphenyl-1H-pyrazol-4-yl)-N-(3-methoxyphenyl)methanimine 11e
Yield 71%, m.p. 270-272°C. Anal. Calcd for C 23 
-( ( ( 1 , 3 -D i p h e n y l -1 H -p y r a z o l -4 -y l ) methylene)amino)aniline 11f
Yield 62%, m.p. p-aminothiophenol, thioethanol, 2-hydroxythioethanol)were refluxed in ethanol (20 mL) containing three drops of triethylamine for 3 hours then the product formed was filtered, dried and recrystallized from ethanol to give 15a-e
Method B:
A mixture of compound 6 (2.96 g, 0.01 mole), malononitrile (0.66 g, 0.01 mole) and thiol derivativess l3a-e (0.01 mole) were refluxed in ethanol (20 mL) containing three drops of triethylamine for 3 hours, then the product formed was filtered off, dried and recrystallized from ethanol to give 15a-e.
2-Amino-4-(1,3-diphenyl-1H-pyrazol-4-yl)-6-(phenylthio)pyridine-3,5-dicarbonitrile 15a
Yield 57%, m.p. 
-A m i n o -6 -( ( -a m i n o p h e n y l ) t h i o ) -4 -(1,3-diphenyl-1H-pyrazol-4-yl)pyridine-3,5-dicarbonitrile 15b
Yield 55%, m.p. 250-251°C. IR (KBr, cm 
-A m i n o -6 -( ( 4 -a m i n o p h e n y l ) t h i o ) -4 -(1,3-diphenyl-1H-pyrazol-4-yl)pyridine-3,5-dicarbonitrile 15c
Yield 60%, m.p. 260-262°C, IR (KBr, cm 
2-Amino-4-(1,3-diphenyl-1H-pyrazol-4-yl)-6-(ethylthio)pyridine-3,5-dicarbonitrile 15d
Yield 62%, m.p. 
2-Amino-4-(1,3-diphenyl-1H-pyrazol-4-yl)-6-((2-hydroxyethyl)thio)pyridine-3,5-dicarbonitrile

Synthesis of 2-amino-4-(1,3-diphenyl-1H-pyrazol4yl)-6-hydroxy pyridine-3,5-dicarbonitrile 16.
2-Amino-4-(1,3-diphenyl-1H-pyrazol-4-yl)-6-(phen ylthio)-pyridine-3,5-dicarbnonitrile 15a (0.47 g, 0.001 mole) was refluxed in ethanolic NaOH 30% (10 mL) at 120°C with stirring for 5 hours, the reaction was then cooled, the solid separated was filtered off, dried and recrystallized from acetic acid to give compound 16 as colorless crystals in 70% yield, m. 
Synthesis of 3,6-diamino-4-(1,3-diphenylpyrazol-4-yl)pyrazolo[3,4-b]pyridine-5-carbontrile 17.
A solution of 2-amino-4-(1,3-diphenyl-1H-pyrazol-4-yl)-6-(phenylthio)pyridine-3,5-dicarbonitrile 15a (4.70 g, 0.01 mole) or 2-amino-6-chloro-4- (1,3,-diphenyl-1H-pyrazol-4-yl) 
Synthesis of 2-amino-6-choloro-4-(1,3-diphenyl-1H-pyrazol-4-yl) pyridine-3,5-dicarbonitrile 18
A mixtures of 2-amino-6-hydroxy-4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine-3,5-dicarbonitrile 16 (3.92 g, 0.01 mole), PCl 5 (2.0 g) and POCl 3 (l0 mL) was heated on water bath for 7 hours, the resulting solution was added dropwise onto crushed ice. The solid product obtained was filtered off, washed several times with water, dried and recrystallized from ethanol to give 2-amino-6-chloro-4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine-3,5-dicarbonitriIe 18 in 62% yield, m.p. > 300°C.
Anal. Calcd for C 22 
A mixture of 2-amino-4-(1,3-diphenyl-1H-pyrazol-4-y1)-6-(phenylthio)-pyridine-3,5-dicarbonitrle 15a (4.70 g, 0.01 mole) or 2-amino-6-chloro-4-(1,3-diphenyl-1H-pyrazol-4-yl) pyridine-3,5-dicarbonitrile 18 (4.70 g, 0.01 mole) and methyl hydrazine (10 mL) was heated with stirring under reflux at 150°C for 3 hours the orange yellow solid formed was separated by filtration, washed with alcohol and recrystallized from ethyl acetate or acetic acid to give the expected product 19 in 75% yield m.p.300°C. 
Synthesis of 3-aryl-2-(1,3-diphenyl-1H-pyrazol-4-yl)thiazolidine-4-one 20a-e [32]
A mixture of 1,3-diphenyl-4-(aryliminomethylene)pyrazole (0.01 mole) and mercaptoacetic acid (1.10 g, 0.012 mole) in dry benzene (80 mL) was refluxed for 15 hours using Dean-Stark separator (to separate the aqueous benzene layer from time to time). Then, evaporate all the solvent, washed the oil residue with petroleum ether 40-60 or ether and recrystallize the yellow solid from methylene chloride or ethyl acetate to give derivatives 20a-e.
2-(1,3-Diphenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one 20a
Yield 50%, m.p. 
2-(1,3-Diphenyl-1H-pyrazol-4-yl)-3-(p-tolyl) thiazolidin-4-one 20b
Yield 50%, m.p. 183-185°C. 
2-(1,3-Diphenyl-1H-pyrazol-4-yl)-3-(4-nitrophenyl)thiazolidin-4-one 20c
Yield 35%, m.p. 
3-(4-Bromophenyl)-2-(1,3-diphenyl-1H-pyrazol-4-yl)thiazolidin-4-one 20d
Yield 
2-(1,3-Diphenyl-1H-pyrazol-4-yl)-3-(4-methoxyphenyl)thiazolidin-4-one 20e
Yield 38%, m.p. 187-189°C. Anal. Calcd for C 25 
Antitumor activity
Human breast adenocarcinoma cell line (MCF-7) and human hepatocarcinoma cell line (Hep-G2) were used to evaluate the cytotoxic effect of the tested drugs. Cells were routinely cultured in DMEM (Dulbeco's Modified Eagle's Medium), which was supplemented with 10% fetal bovine serum (FBS), 2 mML-glutamine, containing 100 units/mL penicillin G sodium, 100 units/mL streptomycin sulphate, and 250 ng/mL amphotericin B. Cells were maintained at subconfluency at 37ºC in humidified air containing 5% CO 2 . For sub-culturing, monolayer cells were harvested after trypsin/EDTA treatment at 37°C. Cells were used when confluence had reached 75%. Tested drugs were dissolved in dimethyl sulphoxide (DMSO), and then diluted thousand times in the assay. Cytotoxicity of tested drugs was measured against MCF-7 and Hep-G2 cells using the MTT Cell Viability Assay. MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) assay is based on the ability of active mitochondrial dehydrogenase enzyme of living cells to cleave the tetrazolium rings of the yellow MTT and form a dark blue insoluble formazan crystals which are largely impermeable to cell membranes, resulting in its accumulation within healthy cells. Solubilization of the cells results in the liberation of crystals, which are then solubilized. The number of viable cells is directly proportional to the level of soluble formazan dark blue color. The extent of the reduction of MTT was quantified by measuring the absorbance at 570 nm [33] . MTT solution was prepared at concentration of 5mg/mL in 0.9%NaCl and acidified isopropanol was prepared by dissolving 0.04 N HCl in absolute isopropanol. Cells (0.5X105 cells/ well), in serum-free media, were plated in a flat bottom 96-well microplate, and treated with 20µL of different concentrations of the tested drugs for 48 h at 37º C, in a humidified 5% CO 2 atmosphere. After incubation, media were removed and 40 µL MTT solution / well were added and incubated for an additional 4 h. MTT crystals were solubilized by adding 180 µL of acidified isopropanol/well and plate was shacked at room temperature, followed by photometric determination of the absorbance at 570 nm using microplate ELISA reader. Triplicate repeats were performed for each concentration and the average was calculated. Data were expressed as the percentage of relative viability compared with the untreated cells compared with the vehicle control, with cytotoxicity indicated by <100% relative viability. Percentage of relative viability was calculated using the following equation:
[Absorbance of treated cells/ Absorbance of control cells)] X 100
Then the half maximal inhibitory concentration (IC 50 ) was calculated from the equation of the dose response curve.
Results and Discussion
1,3-diphenylpyrazole-4-carboxaldehyde
4 was prepared by reaction of acetophenone 1 with phenyl hydrazine 2 and sodium acetate in ethanol; subsequent reaction of benzyl hydrazone3 under Vilsmeier-Haack conditions afforded 1,3-diphenylpyrazole-4-carboxaldehyde 4. The structure of 1,3-diphenylpyrazole-4-carboxaldehyde 4 was confirmed through comparison of its physical data with reported data [28, 29] . The structure of α,β-unsaturated compounds 5a-d were established on the basis of their elemental analysis, spectral data, and comparison of its physical data with reported data [37] . The IR spectrum showed absorption bands at 1668-1627 cm -1 due to carbonyl group, C=N group and 1606-1482 cm -l due to aromatic ring. 2,4,6-trichlorophenyl hydrazine afforded the expected hydrazones 9,10a-e respectively. Also, the condensation reaction of 1,3-diphenylpyrazol-4-carboxaldehyde 4 with aniline derivatives namely; aniline, p-methylaniline, p-nitroaniline, p-bromoaniline, m-methoxyaniline, o-phenylenediamine, 4-nitrom -phenylenediamine, in refluxing methanol containing traces of acetic acid afforded the expected base compounds 11a-g respectively as shown in Scheme 3. In the 1 H NMR spectra of these Schiff bases, the pyrazole H-5 and the azomethine proton resonate as singlets at 8.56 and 8.69 respectively. The structure of compounds 6, 11a-g were confirmed by elemental analysis and spectral data. The IR spectrum of 2-(l,3-diphenyl-1H-pyrazol-4-yl)methylene) malononitrile 6 showed absorption bands at 3068 cm -1 due to CH aromatic, 2200 cm 1H, HC=N-) ppm.It has been reported [38] that the condensation of benzylidenemlononitrile with benzenethiol and malonoitrile was carried out in ethanol containing triethylamine at reflux temperature afforded 2-amino-4-phenyl-3,5-dicyano-6-thoiphenylpyridine 12 [39] . The reaction of N-((1,3-diphenyl-1H-pyrazol-4-yl) methylene-aniline derivatives 11a-e with thioglycolic acid in non-polar solvent at reflux temperature gave 2-(1,3-diphenyl-1H-pyrazol-4-yl)-3-(aryl)-thiozolidine-4-one 20a-e in low yield 20-38% . Structure of all the synthesized compounds, were established by element analysis and spectral data. The IR spectra of 20d showed absorption bands at 3050 cm -1 due to CH aromatic, 2921 cm 
Antitumor activity
Some of the new prepared compounds were screened for antitumor activity. Using MTT assay, the effect of each compound on the proliferation of MCF-7 and Hep-G2 cells were studied after 48 h of incubation. As shown in the figures, the treatment of MCF-7 cells as well as Hep-G2 with some drugs does not show any valuable cytotoxic effect against MCF-7 or Hep G2 as shown in Fig.  1 and 2 respectively concluded from their IC so values >1000 µg/mL while the treatment with the other drugs showed increase in the proliferation of the cells. 
